Valuation: Mesa Laboratories, Inc.

Market Cap 528M 464M 428M 395M 748M 50.38B 761M 5.1B 2B 24.67B 1.98B 1.94B 85.56B P/E 2027 *
70.3x
P/E 2028 * 44.6x
Enterprise Value 528M 464M 428M 395M 748M 50.38B 761M 5.1B 2B 24.67B 1.98B 1.94B 85.56B EV / Sales 2027 *
2.04x
EV / Sales 2028 * 1.94x
Free-Float
94.25%
Yield 2027 *
0.67%
Yield 2028 * 0.67%
1 day+0.23%
1 week-9.41%
Current month-3.96%
1 month-10.94%
3 months-0.24%
6 months+17.76%
Current year+21.80%
1 week 90
Extreme 90
106.04
1 month 87.22
Extreme 87.215
107.79
Current year 71.06
Extreme 71.065
113.99
1 year 55.45
Extreme 55.45
113.99
3 years 55.45
Extreme 55.45
155.12
5 years 55.45
Extreme 55.45
333.42
10 years 55.45
Extreme 55.45
333.42
Manager TitleAgeSince
Chief Executive Officer 56 2026-04-11
Director of Finance/CFO 57 2012-10-28
Comptroller/Controller/Auditor 41 2021-12-31
Director TitleAgeSince
Chairman 73 2017-08-31
Director/Board Member 63 2024-01-04
Director/Board Member 67 2022-06-22
Date Insider Type Main position Quantity % Market Cap.
Jun. 21Sell

Controller/Auditor

-442 0.0080%
Jun. 21Sell

Executive/Senior Manager

-2,516 0.0455%
Jun. 21Sell

Chief Financial Officer

-2,827 0.0512%
Change 5-day change 1-year change 3-year change Capi.($)
+0.23%-9.41%+10.63%-22.96% 528M
-0.50%-1.54%-28.85%-12.62% 164B
+1.80%+0.82%-6.73%-3.92% 107B
+0.32%+2.34%+2.79%+57.04% 59.04B
+0.79%-3.68%+39.99%+54.50% 51.72B
+0.72%-3.88%-13.66%-41.41% 41.87B
+0.47%-4.98% - - 34.7B
+2.66%+5.21%-10.09%-42.88% 28.93B
-1.10%-3.29%+55.70%-5.76% 24.99B
0.00%-1.01%-5.28%-3.57% 21.05B
Average +0.54%-1.89%+4.95%-2.40% 53.38B
Weighted average by Cap. +0.50%-0.94%-5.58%+0.99%

Financials

2027 *2028 *
Net sales 259M 227M 210M 194M 367M 24.72B 374M 2.5B 981M 12.11B 973M 952M 41.98B 272M 239M 220M 203M 386M 25.96B 392M 2.63B 1.03B 12.71B 1.02B 1B 44.08B
Net income 7.57M 6.64M 6.13M 5.66M 10.72M 722M 10.91M 73.02M 28.64M 353M 28.41M 27.79M 1.23B 12.13M 10.65M 9.82M 9.07M 17.19M 1.16B 17.49M 117M 45.93M 567M 45.55M 44.56M 1.97B
Net Debt - -
Logo Mesa Laboratories, Inc.
Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. The Company's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.
Employees
717
Date Price Change Volume
26-07-10 $95.61 +0.23% 166,188
26-07-09 $95.39 +4.41% 329,057
26-07-08 $91.36 -4.99% 644,896
26-07-07 $96.16 -6.24% 151,069
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
95.61USD
Average target price
112.00USD
Spread / Average Target
+17.14%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MLAB Stock